Postreperfusion Liver Biopsy as Predictor of Early Graft Dysfunction and Survival After Orthotopic Liver Transplantation.
J Clin Exp Hepatol
; 12(4): 1133-1141, 2022.
Article
em En
| MEDLINE
| ID: mdl-35814514
ALD, alcohol-related liver disease; ALF, acute liver failure; ALT, alanine aminotransferase; CIHD, chronic ischaemic heart disease; CNI, calcineurin inhibitors; COPD, chronic obstructive pulmonary disease; DBD, donation after brain death; EAD, early allograft dysfunction; H&E, hematoxylin and eosin; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; IGGF, initial good graft function; IQR, interquartile range; IRI, ischaemia/reperfusion injury; MELD, Model for End-stage Liver Disease; OLT, orthotopic liver transplantation; ONT, Organización Nacional de Transplantes; PBC, primary biliary cholangitis; PNF, primary nonfunction; PRB, postreperfusion liver biopsy; SD, standard deviation; STROBE, Strengthening the Reporting of Observational studies in Epidemiology; cold ischemia time; early allograft dysfunction; ischemia reperfusion injury; liver transplantation; postreperfusion biopsy
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article